Related Experiment Videos
Therapy-resistant seizures in pseudohypoparathyroidism. A case report
1Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Israel.
Summary
This study details a pseudohypoparathyroidism case with persistent seizures despite normalized calcium. It explores treatment-resistant convulsion causes and management strategies in this rare endocrine disorder.
Area of Science:
- Endocrinology
- Neurology
- Genetics
Background:
- Pseudohypoparathyroidism (PHP) is a rare genetic disorder characterized by resistance to parathyroid hormone (PTH).
- PHP typically presents with hypocalcemia and hyperphosphatemia, leading to various clinical manifestations including seizures.
Observation:
- A 30-year-old female with intellectual disability presented with refractory seizures.
- Clinical, laboratory, and radiological findings confirmed a diagnosis of pseudohypoparathyroidism.
Findings:
- Despite successful normalization of serum calcium levels through vitamin D therapy, the patient experienced persistent, frequent convulsions.
- This suggests that hypocalcemia may not be the sole cause of seizures in all pseudohypoparathyroidism cases.
Implications:
- The findings highlight the complexity of pseudohypoparathyroidism and the potential for therapy-resistant seizures.
- Further research into the neurobiological mechanisms underlying seizures in PHP is warranted.
- Exploring alternative or adjunctive therapeutic strategies for managing seizures in pseudohypoparathyroidism is crucial.